การนำทาง
แนวโน้มตลาด ตัวคัดกรองหุ้น ปฏิทินการจ่ายเงินปันผล ปฏิทินกิจกรรม อันดับหุ้น ข่าวการตลาด
ทดลองฟรี

Intersect ENT

NASDAQ XENT
- - -%
Today share price
สหรัฐอเมริกา
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 25 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

938.17M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
1.03B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.59
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
33.74M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Intersect ENT

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Intersect ENT

Stock analysis Intersect ENT

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-5.57 8.71
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
-13.58 24.46
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-7.08 4.36
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
-0.61 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
179.10 9.54

Price change Intersect ENT per year

14.68$ 28.17$
Min Max

Summary analysis Intersect ENT

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Intersect ENT

Revenue and net income Intersect ENT

All parameters

Stock news Intersect ENT

All news

About company Intersect ENT

Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL and PROPEL Mini, which are steroid releasing implants for patients undergoing sinus surgery to treat chronic sinusitis; and PROPEL Contour, a steroid releasing implant to frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California.
Address:
1555 Adams Drive, Menlo Park, CA, United States, 94025
Company name: Intersect ENT
Issuer ticker: XENT
ISIN: US46071F1030
Country: สหรัฐอเมริกา
Exchange: NASDAQ
Currency: $
IPO date: 2014-07-24
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.intersectent.com

On which stock exchange are Intersect ENT (XENT) stocks traded?

Intersect ENT (XENT) stocks are traded on NASDAQ.

What is the ticker of Intersect ENT stocks (XENT)?

The stock ticker of Intersect ENT’s stocks or in other words, the code is XENT. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Intersect ENT (XENT) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Intersect ENT (XENT) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Intersect ENT (XENT) stocks traded?

Intersect ENT (XENT) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Intersect ENT (XENT) stocks today?

The current price of Intersect ENT stocks on 19.05.2024 is dollars. per share.

What is the dynamics of Intersect ENT (XENT) stocks from the beginning of the year?

Intersect ENT (XENT) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Intersect ENT (XENT) stocks increase in мае 2024?

This month Intersect ENT (XENT) quotes have increased by 0% to dollars. per share.

How much are Intersect ENT (XENT) stocks worth?

Today, on October, 19.05.2024 Intersect ENT’s (XENT) stocks cost dollars..

What is the market capitalization of Intersect ENT (XENT)?

Capitalization is the market value of Intersect ENT (XENT) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 19.05.2024, the market capitalization of Intersect ENT (XENT) is estimated at about 938170350 dollars.